FDG vs PET/MR for Epilepsy in Children
FDG imaging vs PET/MR for diagnosing children with suspected localization-related epilepsy.
Brain imaging with FDG is as accurate as PET/MR scanning for diagnosis of children with localization-related epilepsy, according to a study published in Pediatric Radiology.
Researchers from Texas, Arizona, and Ohio performed a prospective study to compare the diagnostic accuracy of PET/MR-acquired FDG brain exams to that of PET/CT with respect to identifying seizure foci in children with localization-related epilepsy.
The researchers studied images from 35 patients (median age 11) who had been referred for a diagnosis of localization-related epilepsy; 14 were female. Attenuation-corrected FDG images acquired at PET/MR and PET/CT were interpreted independently by five expert readers who were blinded to the scanner used for acquisition and attenuation correction as well as all other clinical and imaging data. The locale of seizure origin determined at multidisciplinary epilepsy surgery work rounds was considered the reference standard. Non-inferiority testing for paired data was used to compare the diagnostic accuracy of PET/MR to that of PET/CT.
The results showed that image quality did not differ significantly between the two modalities and the accuracy of PET/MR was not inferior to that of PET/CT for localization of a seizure focus.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
